Page 5 - Sohini Das

Lilly's investment reflects long-term commitment to India: Winselow Tucker

Eli Lilly invests $1B in India as Mounjaro succeeds, Hyderabad site to boost global supply and innovation

Weight-based CAFE relief to hurt safer car push: Shailesh Chandra

This is the first time that Chandra has spoken against the demand for weight-based exemption for small cars, which has divided the auto industry since the beginning of this year

Tata Motors posts ₹867 cr loss in Q2, revenue rise 6% to ₹18,585 cr

The margin on earnings before interest, tax, depreciation, and amortisation (Ebitda) stood at 11.4 per cent, up 140 basis points

India's used car mkt hits 5.9 mn units as SUVs, premium models fuel growth

India's pre-owned car market is expanding fast as buyers prioritise SUVs, safer models, trusted brands, and certified dealers - signalling a shift from affordability to aspiration in FY25

Debt restructuring to reduce interest costs by ₹300 cr by FY27: Biocon CEO

CEO Shreehas Tambe says debt reduction, US state tie-ups, and five fresh product launches will strengthen Biocon Biologics' global biosimilar play

EV charging network Bolt.Earth eyes profitability next year; IPO to follow

CEO of India's largest EV charging network says it would be first such firm to turn profitable; expects revenue to grow fourfold in FY27

Medikabazaar targets 40% annual growth as turnaround gains traction

After reporting an 80% revenue jump and EBITDA positivity in Q2FY26, Medikabazaar plans 40% annual growth over the next three years, even as it navigates a high-profile boardroom dispute

Zydus Lifesciences marks China entry with approval for antidepressant drug

Indian pharma firms start get an opening in China; Glenmark got approval for nasal spray earlier

VinFast slightly outsells Tesla in close fight during festival season

Vinfast sold 137 cars versus Tesla's 109 during the festive months of September and October, as BYD maintained a strong lead with over 1,100 cars sold, according to Fada data

Bajaj Auto posts highest ever quarterly revenue and PAT in Q2FY26

Around 20% of domestic revenues now come from electric vehicle business

Exponent Energy targets 2-2.5 million 3Ws with 24-hour EV retrofit

Backed by Hero MotoCorp's Pawan Munjal, Bengaluru-based Exponent Energy's 'Oto' technology can convert ICE three-wheelers to EVs in 24 hours, targeting 2-2.5 million conversions nationwide

Lupin Q2 PAT rises 73% on strong growth across key global markets

Lupin's consolidated profit rose 73% YoY to Rs 1,478 crore in Q2 FY26, led by robust sales in India and the US and higher margins from an improved product mix

Zydus PAT up 38% on strong India, US growth; board okays ₹5K cr fundraise

Zydus Lifesciences reported a 17% YoY rise in revenue to Rs 6,123 crore and a 38% jump in profit to Rs 1,258.6 crore in Q2 FY26, driven by India and US formulations performance

Sun Pharma Q2 net profit rises 2.5% to ₹3,118 crore on India, EM growth

Sun Pharma's Q2FY26 profit rose to Rs 3,118 crore as India, emerging markets, and rest of world drove growth; US revenues fell 4.1% despite strong gains in innovative medicines

M&M to sell entire 3.45% stake in RBL Bank via ₹682-cr block deal

The automaker's full exit from RBL Bank via a Rs 682 crore block deal brings a 64 per cent return on its year-old investment

M&M Q2 results: Profit rises 16% on strong auto and farm showing

The company reported consolidated PAT of ₹3,673 crore and 22% revenue growth in Q2 FY26, led by robust SUV sales, record tractor volumes, and higher margins across segments

'Bumper' October as two-wheeler retail sales top 2.8 million units

Hero MotoCorp nears 1 million retail sales, Bajaj tops EV chart as strong rural demand and GST boost lift festive momentum

GST 2.0 drives two-wheeler owners to car showrooms, boosts Maruti

GST 2.0 price cuts are bringing a new set of first-time car buyers into Maruti showrooms, with small car bookings rising sharply and a focused campaign launched to ease financing

October car retail outpaces OEM dispatches to dealers, aided by GST reforms

Retail sales, however, outpaced wholesales as vehicles continued to move swiftly out of showrooms

USFDA's new biosimilar norms to woo more players, fast-track mkt entry

Indian cos like Biocon, DRL, Intas, Lupin stand to benefit from the proposed move